Dolby Laboratories (DLB) EPS (Weighted Average and Diluted) Growth (3y) (2016 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
| 1 |
Relx |
81.40 Bn |
81.16 Bn |
- |
- |
| 2 |
Rentokil Initial |
79.56 Bn |
78.10 Bn |
- |
- |
| 3 |
Cintas |
69.26 Bn |
69.08 Bn |
1.45 Bn |
-26.63% |
| 4 |
Copart |
33.09 Bn |
28.01 Bn |
971.24 Mn |
6.27% |
| 5 |
UL Solutions |
20.56 Bn |
20.32 Bn |
381.00 Mn |
17.13% |
| 6 |
Global Payments |
19.88 Bn |
14.69 Bn |
1.70 Bn |
-169.16% |
| 7 |
Rb Global |
19.08 Bn |
18.89 Bn |
869.50 Mn |
63.33% |
| 8 |
Aramark |
13.57 Bn |
13.16 Bn |
426.35 Mn |
96.61% |
| 9 |
Amentum Holdings |
5.65 Bn |
5.74 Bn |
345.00 Mn |
- |
| 10 |
Dolby Laboratories |
5.15 Bn |
4.56 Bn |
350.90 Mn |
0.34% |
| Date | Value |
|---|
| Mar 27, 2026 |
0.34% |
| Dec 26, 2025 |
-12.46% |
| Sep 26, 2025 |
20.70% |
| Jun 27, 2025 |
7.17% |
| Mar 28, 2025 |
37.70% |
| Dec 27, 2024 |
-3.13% |
| Sep 27, 2024 |
11.74% |
| Jun 28, 2024 |
-8.37% |
| Mar 29, 2024 |
11.43% |
| Dec 29, 2023 |
-19.03% |
| Sep 29, 2023 |
-29.79% |
| Jun 30, 2023 |
-36.37% |
| Mar 31, 2023 |
4.45% |
| Dec 30, 2022 |
20.38% |
| Sep 30, 2022 |
-12.30% |
| Jul 1, 2022 |
0.87% |
| Apr 1, 2022 |
-19.88% |
| Dec 31, 2021 |
-6.10% |
| Sep 24, 2021 |
19.81% |
| Jun 25, 2021 |
158.80% |
| Mar 26, 2021 |
6.17% |
| Dec 25, 2020 |
65.10% |
| Sep 25, 2020 |
7.38% |
| Jun 26, 2020 |
-3.30% |
| Mar 27, 2020 |
20.62% |
| Dec 27, 2019 |
-2.69% |
| Sep 27, 2019 |
23.19% |
| Jun 28, 2019 |
-15.06% |
| Mar 29, 2019 |
1.98% |
| Dec 28, 2018 |
45.81% |
| Sep 28, 2018 |
-17.79% |
| Jun 29, 2018 |
-55.48% |
| Mar 30, 2018 |
2.89% |
| Dec 29, 2017 |
-48.88% |
| Sep 29, 2017 |
-21.85% |
| Jun 30, 2017 |
24.31% |
| Mar 31, 2017 |
-12.44% |
| Dec 30, 2016 |
5.85% |
| Sep 30, 2016 |
-19.45% |
| Jul 1, 2016 |
28.82% |
